Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,784 | -44,137 | -7,870 | -54,410 | -70,539 |
| Depreciation Amortization | 11,543 | 11,432 | 3,317 | 2,602 | 6,695 |
| Accounts receivable | -10,372 | 1,094 | -3,073 | 7,352 | -5,353 |
| Other Working Capital | 12,184 | -9,957 | -5,341 | 31,977 | -1,730 |
| Other Operating Activity | 17,997 | 5,809 | 6,587 | 2,660 | 37,948 |
| Operating Cash Flow | $-52,432 | $-35,759 | $-6,380 | $-9,819 | $-32,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -562 | -159 | -995 | -1,024 | -913 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,500 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -1,500 | 0 |
| Investing Cash Flow | $-562 | $-159 | $-995 | $-2,524 | $-913 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 31,144 | N/A | N/A |
| Debt Repayment | -26 | -23 | -53,631 | -2,025 | 0 |
| Common Stock Issued | 103,464 | 84,721 | 17,259 | 13,620 | 30,123 |
| Other Financing Activity | -821 | -1,106 | 9,202 | -3 | -14 |
| Financing Cash Flow | $102,617 | $83,592 | $3,974 | $11,592 | $30,109 |
| Beginning Cash Position | 71,546 | 23,872 | 27,273 | 28,024 | 31,807 |
| End Cash Position | 121,169 | 71,546 | 23,872 | 27,273 | 28,024 |
| Net Cash Flow | $49,623 | $47,674 | $-3,401 | $-751 | $-3,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,432 | -35,759 | -6,380 | -9,819 | -32,979 |
| Capital Expenditure | -562 | -159 | -995 | -1,024 | -913 |
| Free Cash Flow | -52,994 | -35,918 | -7,375 | -10,843 | -33,892 |